sample_id	patient_name	dataset_id	dataset_group	Treatment	response	response_NR	M Stage	overall survival (days)	vital status	Total Mutation	Gender	Therapy	age_start	tumor_type	seq_type	id
SRR3184279	Pt1	GSE78220	Melanoma_GSE78220	PRE	PD	N	M1B	607.0	Dead	1638	Female	anti-PD-1	66	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184280	Pt2	GSE78220	Melanoma_GSE78220	PRE	R	R	M1C	927.0	Alive	1868	Male	anti-PD-1	55	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184281	Pt4	GSE78220	Melanoma_GSE78220	PRE	R	R	M1C	948.0	Alive	3727	Male	anti-PD-1	62	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184282	Pt5	GSE78220	Melanoma_GSE78220	PRE	R	R	M1C	439.0	Alive	312	Male	anti-PD-1	61	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184283	Pt6	GSE78220	Melanoma_GSE78220	PRE	R	R	M1C	882.0	Alive	207	Male	anti-PD-1	51	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184284	Pt7	GSE78220	Melanoma_GSE78220	PRE	PD	N	M1C	662.0	Dead	1184	Female	anti-PD-1	55	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184286	Pt9	GSE78220	Melanoma_GSE78220	PRE	R	R	M0	1054.0	Alive	474	Male	anti-PD-1	68	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184287	Pt10	GSE78220	Melanoma_GSE78220	PRE	PD	N	M1A	387.0	Alive	225	Male	anti-PD-1	60	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184288	Pt12	GSE78220	Melanoma_GSE78220	PRE	PD	N	M1C	327.0	Dead	50	Male	anti-PD-1	59	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184289	Pt13	GSE78220	Melanoma_GSE78220	PRE	R	R	M1C	917.0	Alive	428	Female	anti-PD-1	53	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184290	Pt14	GSE78220	Melanoma_GSE78220	PRE	PD	N	M1C	54.0	Alive	1457	Female	anti-PD-1	27	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184291	Pt15	GSE78220	Melanoma_GSE78220	PRE	R	R	M1B	980.0	Dead	514	Male	anti-PD-1	70	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184292	Pt16	GSE78220	Melanoma_GSE78220	ON	PD	N	M1B	186.0	Dead	519	Male	anti-PD-1	19	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184293	Pt19	GSE78220	Melanoma_GSE78220	PRE	R	R	M1C	1060.0	Alive	618	Male	anti-PD-1	45	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184294	Pt20	GSE78220	Melanoma_GSE78220	PRE	PD	N	M1C	337.0	Dead	542	Female	anti-PD-1	63	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184295	Pt22	GSE78220	Melanoma_GSE78220	PRE	PD	N	M1C	182.0	Dead	68	Male	anti-PD-1	55	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184296	Pt23	GSE78220	Melanoma_GSE78220	PRE	PD	N	M1C	103.0	Dead	233	Male	anti-PD-1	63	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184297	Pt25	GSE78220	Melanoma_GSE78220	PRE	PD	N	M1C	262.0	Dead	110	Male	anti-PD-1	74	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184298	Pt27A	GSE78220	Melanoma_GSE78220	PRE	R	R	M1C	548.0	Alive	2297	Male	anti-PD-1	83	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184299	Pt27B	GSE78220	Melanoma_GSE78220	PRE	R	R	M1C	548.0	Alive	2297	Male	anti-PD-1	83	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184300	Pt28	GSE78220	Melanoma_GSE78220	PRE	R	R	M1C	439.0	Dead	465	Male	anti-PD-1	82	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184301	Pt29	GSE78220	Melanoma_GSE78220	PRE	PD	N	M1C	269.0	Dead	225	Male	anti-PD-1	84	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184302	Pt31	GSE78220	Melanoma_GSE78220	PRE	PD	N	M1C	704.0	Alive	594	Male	anti-PD-1	47	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184303	Pt32	GSE78220	Melanoma_GSE78220	PRE	PD	N	M1C	171.0	Dead	259	Male	anti-PD-1	47	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184304	Pt35	GSE78220	Melanoma_GSE78220	PRE	R	R	M1C	427.0	Alive	313	Female	anti-PD-1	65	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184305	Pt37	GSE78220	Melanoma_GSE78220	PRE	R	R	M1C	364.0	Alive	553	Female	anti-PD-1	70	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
SRR3184306	Pt38	GSE78220	Melanoma_GSE78220	PRE	R	R	M1C	448.0	Alive	78	Female	anti-PD-1	57	Melanoma	RNA-seq	Melanoma_GSE78220_anti-PD-1
